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INTRODUCTION
Isolated plasmacytomas may arise from either bones or extraosseous tissue.
Extraosseous plasmacytomas, also known as extramedullary plasmacytoma (EMP), are commonly found in the upper respiratory tract, including the nasal cavity, nasopharynx and sinuses. [1] [2] [3] [4] Very rarely, isolated plasmacytoma can occur within the cranium, which is also called solitary intracranial plasmacytoma (SIP). To date, only 20 cases of SIP have been reported in English literature. 5 Similar to other plasmacytomas, SIPs are composed of neoplastic plasma cells; however occasionally, the morphology of these plasma cells on frozen sections may not be plasmacytoid, presenting a diagnostic challenge to the pathologist. Here we report such a case with discussion of differential diagnoses, management and prognosis of SIP. 
CASE REPORT
The patient was an otherwise healthy 40-year-old white male, presenting with cloudiness of vision and horizontal binocular diplopia. A T1-weighted sagittal MRI revealed a large expansile, homogeneously enhancing, well-defined, noninfiltrating mass within the clivus with extension anteriorly into the posterior aspect of the sphenoid sinus, inferiorly to the anterior arch of C1 and superiorly to the level of the pituitary fossa (Figure 1) . A transnasal endoscopic biopsy was performed.
Frozen sections showed sheets of pleomorphic cells with abundant eosinophilic cytoplasm and round/oval nuclei with stippled chromatin (Figure 2A) . On touch prep, naked nuclei with homogenous/salt and pepper chromatin, mild crush artifacts and rare plasmacytoid cells were noted ( Figure 2B) . A frozen section diagnosis of "unclassified neoplasm, defer to permanent sections" was made. On permanent sections, the neoplastic cells showed a striking plasmacytoid configuration ( Figure 2C ). To further characterize the neoplasm, immunohistochemical studies
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were performed. The tumor cells are positive for CD138, CD56, Bcl-1, and kappa light chain, and negative for lambda light chain and chromogranin A (Figure 3) . Tumor cells also lack expression of CD20 and HHV-8 (not shown). ISH study performed for EBV (EBER) is also negative (not shown). The proliferation index, assessed with Ki67 antibody, was 5-10%, indicating that the active proliferation of the tumor was low. The immunostaining patterns favored a kappa-lightchain-restricted plasmacytoma over other differential diagnoses (B-cell lymphoma, neuroendocrine tumor and NK/T cell tumor). To rule out systemic disease, a subsequent complete work up was performed. The patient's CBC was unremarkable. His bone marrow biopsy and aspirate smear showed no increase in plasma cells and flow cytometry revealed no evidence of plasma cell dyscrasia. A full skeletal survey was negative. He had a serum M-spike of 0.75 g/dL at that time, but his quantitative immunoglobulins, kappa or lamda free light chains and beta-2 microglobulin were within normal limits. The patient received radiation therapy accompanied by high-dose dexamethasone. Four months post-radiation, although the patient was asymptomatic, a surveillance MRI showed a similar mass in the same area and PET scan showed increased FDG uptake. His serum M-spike had dropped to 0.3 g/dL during his radiation therapy, but persisted at this level subsequently. The diagnosis of persistent residual plasmacytoma was reached. The patient underwent gamma knife radiosurgery and tolerated the procedure well. Three months after the surgery, the patient's M-spike was undetectable. In summary, the morphological features, immunohistochemical studies and the complete work up results support the diagnosis of SIP. 
DISCUSSION
Plasmacytoma is a localized clonal proliferation of plasma cells arising from bone or extraosseous soft tissues. Due to architectural and cytological variations of plasmacytoma, the diagnosis of this entity may be difficult, and further complicated by freezing artifacts and rare locations. About 90% of EMPs arises from the head and neck [6] [7] and 80% of head and neck EMPs occurs in the upper aerodigestive tract. 8 SIP is extremely rare with only 20 cases reported in the literature and only a few case soccurred in the clivus. 5 The diagnosis of SIP requires demonstration of monoclonality and/or an aberrant plasma cell phenotype without evidence of systemic disease. Light chain restriction strongly supports plasma cell clonality, ruling out the reactive plasmacytosis and plasma cell granuloma. Aberrant expression of CD56 and/or cyclin D1 also support a neoplastic origin. Negative CD20 staining rules out B cell lymphomas with marked plasmacytic differentiation (marginal zone lymphoma and lymphoplasmacytic lymphoma). If low level of monoclonal protein in serum or urine is detected, normal levels of uninvolved immunoglobulins are required to confirm the absence of systemic involvement. 1 The prognosis of EMPs is better than that of solitary bone plasmacytoma (SBP), due to a higher local control rate by radiotherapy and a less likelihood of progression to plasma cell myeloma. 3, 9 The skull base including the clivus is rich in marrow, whether the plasmacytoma arising from this region belong to EMP or SBP has not been clearly defined. 10 Schwartz et al 11 have shown that the most powerful predictor for developing plasma cell myeloma among SIP was cranial base location and the expression of CD56 had no value in predicting patients' outcome.
To conclude, the diagnosis of SIP could be challenging, especially on frozen sections, due to the freezing artifacts and rarity of this entity. SIP might be radio-insensitive and close follow-up of the patient is warranted.
